Reizes O - Search Results

1

Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity.

Su H, Gunter JH, de Vries M, Connor T, Wanyonyi S, Newell FS, Segal D, Molero JC, Reizes O, Prins JB, Hutley LJ, Walder K, Whitehead JP. Su H, et al. Among authors: reizes o. Biochem Biophys Res Commun. 2009 Aug 21;386(2):351-5. doi: 10.1016/j.bbrc.2009.06.040. Epub 2009 Jun 11. Biochem Biophys Res Commun. 2009. PMID: 19523919

2

D-myo-inositol (1,4)-bisphosphate 1-phosphate. Partial purification from rat liver and characterization.

Moyer JD, Reizes O, Dean NM, Malinowski N. Moyer JD, et al. Among authors: reizes o. Biochem Biophys Res Commun. 1987 Aug 14;146(3):1018-26. doi: 10.1016/0006-291x(87)90749-2. Biochem Biophys Res Commun. 1987. PMID: 3039989

3

Diet-induced obese mice are leptin insufficient after weight reduction.

Shi H, Akunuru S, Bierman JC, Hodge KM, Mitchell MC, Foster MT, Seeley RJ, Reizes O. Shi H, et al. Among authors: reizes o. Obesity (Silver Spring). 2009 Sep;17(9):1702-9. doi: 10.1038/oby.2009.106. Epub 2009 Apr 16. Obesity (Silver Spring). 2009. PMID: 19373220 Free PMC article.

4

Mice lacking the syndecan-3 gene are resistant to diet-induced obesity.

Strader AD, Reizes O, Woods SC, Benoit SC, Seeley RJ. Strader AD, et al. Among authors: reizes o. J Clin Invest. 2004 Nov;114(9):1354-60. doi: 10.1172/JCI20631. J Clin Invest. 2004. PMID: 15520868 Free PMC article.

5

Small-molecule melanin-concentrating hormone-1 receptor antagonists require brain penetration for inhibition of food intake and reduction in body weight.

Eric Hu X, Wos JA, Dowty ME, Suchanek PM, Ji W, Chambers JB, Benoit SC, Clegg DJ, Reizes O. Eric Hu X, et al. Among authors: reizes o. J Pharmacol Exp Ther. 2008 Jan;324(1):206-13. doi: 10.1124/jpet.107.130435. Epub 2007 Oct 11. J Pharmacol Exp Ther. 2008. PMID: 17932246

6

Substrate properties of analogs of myo-inositol.

Moyer JD, Reizes O, Ahir S, Jiang C, Malinowski N, Baker DC. Moyer JD, et al. Among authors: reizes o. Mol Pharmacol. 1988 Jun;33(6):683-9. Mol Pharmacol. 1988. PMID: 2837638

7

Syndecan-3 modulates food intake by interacting with the melanocortin/AgRP pathway.

Reizes O, Benoit SC, Strader AD, Clegg DJ, Akunuru S, Seeley RJ. Reizes O, et al. Ann N Y Acad Sci. 2003 Jun;994:66-73. doi: 10.1111/j.1749-6632.2003.tb03163.x. Ann N Y Acad Sci. 2003. PMID: 12851299

8

A role for syndecan-3 in the melanocortin regulation of energy balance.

Reizes O, Clegg DJ, Strader AD, Benoit SC. Reizes O, et al. Peptides. 2006 Feb;27(2):274-80. doi: 10.1016/j.peptides.2005.02.030. Epub 2005 Nov 11. Peptides. 2006. PMID: 16289473 Review.

9

The effects of the melanocortin agonist (MT-II) on subcutaneous and visceral adipose tissue in rodents.

Strader AD, Shi H, Ogawa R, Seeley RJ, Reizes O. Strader AD, et al. Among authors: reizes o. J Pharmacol Exp Ther. 2007 Sep;322(3):1153-61. doi: 10.1124/jpet.107.123091. Epub 2007 Jun 13. J Pharmacol Exp Ther. 2007. PMID: 17567964

10

The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity.

Seeley RJ, Burklow ML, Wilmer KA, Matthews CC, Reizes O, McOsker CC, Trokhan DP, Gross MC, Sheldon RJ. Seeley RJ, et al. Among authors: reizes o. Endocrinology. 2005 Sep;146(9):3732-8. doi: 10.1210/en.2004-1663. Epub 2005 Jun 2. Endocrinology. 2005. PMID: 15932932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page